Fig. 4From: Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effectsIFN-γ levels of both groups before and after treatment. There is no difference in the IFN-γ levels between the two groups before treatment, but the levels increased remarkably after treatment, and those in group B were higher than those in group A (p<0.05). Note: *p<0.05Back to article page